SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-077550
Filing Date
2014-12-22
Accepted
2014-12-22 20:04:59
Documents
1
Period of Report
2014-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9740
  Complete submission text file 0001209191-14-077550.txt   11204
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Issuer) CIK: 0001411158 (see all company filings)

IRS No.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303
Business Address
Chanda Sanjay (Reporting) CIK: 0001571820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34973 | Film No.: 141304408